Abstract
Amylase genes reside in a structurally complex locus, and their copy numbers vary greatly, especially among agricultural races. Amylase genes seem to shape the metabolic response to dietary starch, and several studies have reported their association with obesity. Besides, the effect of amylase copy numbers seems to depend on lifestyle, and the mechanism of this effect was partially explained by changes in the oral and gut microbiome compositions; however, a detailed mechanism has been unclarified. In this study, we showed their association with diabetes in addition to obesity, and further discovered a plausible mechanism of this association based on the function of commensal bacterial in a northern Japanese population. First, we confirmed that the amylase copy number in the population tends to be larger than that reported in other studies and that there is a positive association between obesity and diabetes (p =1.95E-2 and 3.28E-2). Second, we identified that relative abundance of some genus level microbiome, Capnocytophaga, Dialister, and previously reported bacteria, were significantly associated with amylase copy numbers. Finally, through functional gene-set analysis using shotgun sequencing, we observed that the abundance of genes in the Acarbose pathway in the gut microbiome was significantly decreased with an increase in the amylase copy number (p-value = 5.80E-4), which can partly explain the mechanism underlying obesity and diabetes in populations with high amylase copy numbers.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by JST COI Grant Number JPMJCE1302. This research used the supercomputing resources provided by the Human Genome Center, Institute of Medical Science, University of Tokyo (http://sc.hgc.jp/shirokane.html).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study design was approved by the Hirosaki University Hospital Institutional Review Board (Protocol Number Num. 2017-026). Written informed consent was obtained from all the patients in this study. No animal experiments were conducted in this study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
E-mail addresses: mkakuta{at}ims.u-tokyo.ac.jp (M. Kakuta), ruiy{at}ims.u-tokyo.ac.jp (R. Yamaguchi), nori5030{at}kuhp.kyoto-u.ac.jp (N. Sato), tmika{at}hirosaki-u.ac.jp (T. Mikami), murasita{at}hirosaki-u.ac.jp (K. Murashita), nakaji{at}hirosaki-u.ac.jp (S. Nakaji), itohk{at}hirosaki-u.ac.jp (K. Itoh).
Data Availability
The datasets supporting the current study have not been deposited in a public repository [because the data are not public] but are available from the corresponding author, S.I., on request.
